Concepedia

Publication | Open Access

Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

DOIFull Paper Access

57

Citations

22

References

2021

Year

Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun,
Clinical Cancer Research

Abstract

In this first randomized trial in patients with ACC, axitinib significantly increased the 6-month PFS rate as compared with observation. (ClinicalTrials.gov number, NCT02859012).

References

YearCitations

Page 1